FDA Grants First of its Kind Indication for Chronic Sleep Disorder Treatment
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently approved a new indication for Xywav for idiopathic hypersomnia (IH) in adults. IH is an uncommon chronic sleep disorder that …
FDA Grants First of its Kind Indication for Chronic Sleep Disorder Treatment Read More